Login

Financial Snapshot

Revenue
TTM
$27.14M
Gross Margin
TTM
11.52%
Net Income
TTM
$120.0K
Current Assets
2025 Q3
$8.860M
Current Liabilities
2025 Q3
$3.030M
Current Ratio
2025 Q3
292.41%
Total Assets
2025 Q3
$9.630M
Total Liabilities
2025 Q3
$4.490M
Book Value
2025 Q3
5.140M
Cash
Last 4 Quarters
N/A
P/E
TTM
50.41
Free Cash Flow
TTM
-$280.0K

Stock Price

Loading...
Market Cap: $6.0489 Million

About Cellyan Biotechnology Co Ltd

Cellyan Biotechnology Ltd. engages in providing pharmaceutical cross-border e-commerce supply chain services. The company employs 27 full-time employees The company went IPO on 2025-01-15. The firm mainly provides two services. The supply chain services mainly provide OTC pharmaceutical cross-border e-commerce supply chain services. The procurement and distribution services mainly provide OTC pharmaceutical cross-border procurement and distribution services.

Industry: Wholesale-Drugs, Proprietaries & Druggists' Sundries

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support